Literature DB >> 31444803

Validation of a composite vascular high-risk profile for adult patients with sickle cell disease.

Mehdi Nouraie1, Jane A Little2, Mariana Hildesheim1, J Simon R Gibbs3, Claudia R Morris4, Roberto F Machado5, Gregory J Kato1, Victor R Gordeuk6, Mark T Gladwin1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31444803      PMCID： PMC7194466          DOI： 10.1002/ajh.25624

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  10 in total

1.  Clustering of end-organ disease and earlier mortality in adults with sickle cell disease: A retrospective-prospective cohort study.

Authors:  Shruti Chaturvedi; Djamila Labib Ghafuri; Natalie Jordan; Adetola Kassim; Mark Rodeghier; Michael R DeBaun
Journal:  Am J Hematol       Date:  2018-07-30       Impact factor: 10.047

Review 2.  cGMP modulation therapeutics for sickle cell disease.

Authors:  Nicola Conran; Lidiane Torres
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-28

3.  A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.

Authors:  Elliott Vichinsky; Carolyn C Hoppe; Kenneth I Ataga; Russell E Ware; Videlis Nduba; Amal El-Beshlawy; Hoda Hassab; Maureen M Achebe; Salam Alkindi; R Clark Brown; David L Diuguid; Paul Telfer; Dimitris A Tsitsikas; Ashraf Elghandour; Victor R Gordeuk; Julie Kanter; Miguel R Abboud; Joshua Lehrer-Graiwer; Margaret Tonda; Allison Intondi; Barbara Tong; Jo Howard
Journal:  N Engl J Med       Date:  2019-06-14       Impact factor: 91.245

4.  Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia.

Authors:  S T Miller; E Wright; M Abboud; B Berman; B Files; C D Scher; L Styles; R J Adams
Journal:  J Pediatr       Date:  2001-12       Impact factor: 4.406

Review 5.  Intravascular hemolysis and the pathophysiology of sickle cell disease.

Authors:  Gregory J Kato; Martin H Steinberg; Mark T Gladwin
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

6.  N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease.

Authors:  Roberto F Machado; Anastasia Anthi; Martin H Steinberg; Duane Bonds; Vandana Sachdev; Gregory J Kato; Angelo M Taveira-DaSilva; Samir K Ballas; William Blackwelder; Xiuli Xu; Lori Hunter; Bruce Barton; Myron Waclawiw; Oswaldo Castro; Mark T Gladwin
Journal:  JAMA       Date:  2006-07-19       Impact factor: 56.272

7.  Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.

Authors:  Paul Drawz; Sabarish Ayyappan; Mehdi Nouraie; Santosh Saraf; Victor Gordeuk; Thomas Hostetter; Mark T Gladwin; Jane Little
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-15       Impact factor: 8.237

8.  Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease.

Authors:  Kenneth I Ataga; Abdullah Kutlar; Julie Kanter; Darla Liles; Rodolfo Cancado; João Friedrisch; Troy H Guthrie; Jennifer Knight-Madden; Ofelia A Alvarez; Victor R Gordeuk; Sandra Gualandro; Marina P Colella; Wally R Smith; Scott A Rollins; Jonathan W Stocker; Russell P Rother
Journal:  N Engl J Med       Date:  2016-12-03       Impact factor: 91.245

9.  Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev; Maria L Jison; Yukitaka Shizukuda; Jonathan F Plehn; Karin Minter; Bernice Brown; Wynona A Coles; James S Nichols; Inez Ernst; Lori A Hunter; William C Blackwelder; Alan N Schechter; Griffin P Rodgers; Oswaldo Castro; Frederick P Ognibene
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245

10.  Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom.

Authors:  Mark T Gladwin; Robyn J Barst; J Simon R Gibbs; Mariana Hildesheim; Vandana Sachdev; Mehdi Nouraie; Kathryn L Hassell; Jane A Little; Dean E Schraufnagel; Lakshmanan Krishnamurti; Enrico Novelli; Reda E Girgis; Claudia R Morris; Erika Berman Rosenzweig; David B Badesch; Sophie Lanzkron; Oswaldo L Castro; James G Taylor; Jonathan C Goldsmith; Gregory J Kato; Victor R Gordeuk; Roberto F Machado
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240
  10 in total
  1 in total

1.  Exercise-induced changes of vital signs in adults with sickle cell disease.

Authors:  Solomon Johnson; Victor R Gordeuk; Roberto Machado; J Simon R Gibbs; Mariana Hildesheim; Jane A Little; Gregory J Kato; Mark T Gladwin; Mehdi Nouraie
Journal:  Am J Hematol       Date:  2021-10-20       Impact factor: 10.047
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.